Mein Warenkorb

COMP

COMP Molekülinformation

Englischer NameSodium channel protein type VIII alpha subunitAnzahl der inverkehr gebrachten Arzneimittel1
Anzahl der klinischen Arzneimittel4Target-AliasSodium Channel, Voltage Gated, Type VIII Alpha Subunit,Voltage-Gated Sodium Channel Type VIII Alpha Protein,HNa6/Scn8a Voltage-Gated Sodium Channel,CERIII,EIEE13,Nav1.6,BFIS5,NaCh6,CIAT,PN4,NAV1.6 Voltage-Gated Sodium Channel,MYOCL2,Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha,MED,SCN8A,Sodium Voltage-Gated Channel Alpha Subunit 8,Sodium Channel, Voltage Gated, Type VIII, Alpha Subunit,Voltage-Gated Sodium Channel Subunit Alpha Nav1.6,Sodium Channel, Voltage Gated, Type VIII, Alpha Polypeptide
Höchste Forschungs- und EntwicklungsphaseApproved
Englischer NameSodium channel protein type VIII alpha subunit
Target-AliasSodium Channel, Voltage Gated, Type VIII Alpha Subunit,Voltage-Gated Sodium Channel Type VIII Alpha Protein,HNa6/Scn8a Voltage-Gated Sodium Channel,CERIII,EIEE13,Nav1.6,BFIS5,NaCh6,CIAT,PN4,NAV1.6 Voltage-Gated Sodium Channel,MYOCL2,Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha,MED,SCN8A,Sodium Voltage-Gated Channel Alpha Subunit 8,Sodium Channel, Voltage Gated, Type VIII, Alpha Subunit,Voltage-Gated Sodium Channel Subunit Alpha Nav1.6,Sodium Channel, Voltage Gated, Type VIII, Alpha Polypeptide
Anzahl der inverkehr gebrachten Arzneimittel1
Anzahl der klinischen Arzneimittel4
Höchste Forschungs- und EntwicklungsphaseApproved

COMP Produktliste

  • Attribut

    Protein (1)

  • Produktbibliothek

    Online (1)

  • Spezies

    Human (1)

  • Etikett

    His Tag (1)

  • Marker

    Unconjugated (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
COP-H5220
Human
HEK293
Human COMP / TSP5 Protein, His Tag
In den Warenkorb legen
Gesamtmenge1
  • 1

COMP Molekülhintergrund

Cartilage oligomeric matrix protein (COMP) is also known as Thrombospondin-5 (TSP5), EDM1, EPD1, MED, PSACH, THBS5, which belongs to the thrombospondin family. COMP / TSP5 contains 4 EGF-like domains, 1 TSP C-terminal (TSPC) domain, 8 TSP type-3 repeats. Abundantly expressed in the chondrocyte extracellular matrix, and is also found in bone, tendon, ligament and synovium and blood vessels. COMP may play a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. COMP can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors. Thrombospondin-5 could play a role in the pathogenesis of osteoarthritis. COMP is a marker of cartilage turnover.

COMP Molekülalias

COMP,TSP5,EDM1,EPD1,MED,PSACH,THBS5

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
PRAX-562PRAX-562Phase 3 ClinicalPraxis Precision MedicinesBrain Diseases; Epilepsy
Details
XEN-901NBI-921352; XEN-901Phase 2 ClinicalXenon PharmaEpilepsies, Partial; Brain Diseases; Epilepsy
Details
PRAX-330GS-458967; GS-967; PRAX-330Phase 1 ClinicalPraxis Precision Medicines IncEpilepsy
Details
NBI-355NBI-355Phase 1 ClinicalNeurocrine Biosciences IncEpilepsy
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Pirmenol HydrochlorideCI-845ApprovedSumitomo Dainippon, Pfizer IncPimavar, PimenolJapanArrhythmias, Cardiacnull1994-01-01Arrhythmias, Cardiac
Details
  • Molekülinformation
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns